MedTrace Logo

Closed-loop Glucose Control for Automated Management of Type 1 Diabetes

NCT00811317 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2017-10-25

Study results available
· View outcomes & findings →

Summary

We hypothesize that our integrated closed-loop glucose-control system can provide effective, tight, and safe blood glucose (BG) control in type 1 diabetes, thereby establishing the feasibility of closed-loop BG control.

Conditions

Interventions

DEVICE

Closed-loop

Computer algorithm developed by Firas El-Khatib and Edward Damiano at Boston University that controls sub-cutaneous infusion of insulin and glucagon to regulate blood glucose to target

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • Juvenile Diabetes Research Foundation

    collaborator OTHER

  • Boston University Charles River Campus

    lead OTHER

Principal Investigators

  • Steven J Russell, M.D., Ph.D. · Massachusetts General Hospital

  • Edward Damiano, Ph.D. · Boston University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-10-31
Completion
2009-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00811317 on ClinicalTrials.gov